Medtronic will acquire SPR Therapeutics for $650 million, adding the FDA-cleared SPRINT PNS System for temporary PNS to its ...

CDRH fees doubled repeatedly. Is regulatory expansion justified? One observer says no. Breakthrough devices and TAP programs ...

Endologix has acquired Surmodics' Pounce System, a platform for non-surgical peripheral arterial thrombi removal, expanding ...

Naomi Schwartz, VP of Regulatory Strategy for Medcrypt, talks about the company's offerings to help with cybersecurity.

EmStop has initiated the CAPTURE-2 IDE clinical trial to support the firm’s mission to develop an embolic protection system ...

As competitors rapidly adopt AI, the choice is clear: embrace intelligent automation now or risk falling irreversibly behind ...

It's no secret that the IVL space has been red-hot over the last several years, with more and more big-name players wanting a piece of the pie. What began as a niche calcium modification technology ...

BostonSci secures rights to acquire MiRus' SIEGEL TAVR system with $1.5B equity stake and potential buyout, marking its 3rd ...

Shockwave Medical's CMO discusses the C2 Aero launch, why the company is defining what qualifies as true IVL, and J&J's R&D ...

What’s the next CGM step change, and how is Dexcom going to deliver it? That’s one of the fundamental questions Jake Leach has been asked since stepping into the role of CEO at Dexcom. “I want to make ...